Publications
Scholarly contributions and case documentation arising from the patients Altra Via helps navigate. Shared with patient consent, in de-identified form, for educational and scientific benefit.
A case presented at the Endocrine Society Annual Meeting (ENDO 2026, Tumor Biology — Endocrine Neoplasia), describing a first-reported association between a germline BRCA2 pathogenic variant and parathyroid carcinoma, with response to PARP-inhibitor therapy and a documented acquired resistance mechanism.
Poster · Endocrine Society · June 2026